Macular star formation in diabetic patients with non-arteritic anterior ischemic optic neuropathy (NA-AION)  by Galvez-Ruiz, Alberto
Saudi Journal of Ophthalmology (2015) 29, 71–75Original ArticleMacular star formation in diabetic patients with non-arteritic
anterior ischemic optic neuropathy (NA-AION)Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University Production and hosting by Elsevier
Access this article onlin
www.saudiophthaljourn
www.sciencedirect.com
Received 20 January 2014; received in revised form 7 July 2014; accepted 7 September 2014; available online 16 September 2014.
Neuro-ophthalmology Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
e-mail address: algarui@yahoo.comAlberto Galvez-RuizAbstractBackground: NA-AION is a condition that exhibits a number of unique characteristics in diabetics compared with the rest of the
population. In some diabetic patients with NA-AION, lipid deposits can be observed around the macula forming an incomplete
macular star.
Methods: We describe 12 case studies of patients with NA-AION observing the development of lipid deposits around the macula
forming an incomplete macular star.
Results: All our patients developed some level of lipid deposits around the macula in the form of a macular hemistar in the course
of their illness.
Conclusion: Some authors have suggested that the macular star is formed by transudation from capillaries deep in the optic disk
through the intermediary tissue of Kuhnt, which is located between the retina and the anterior portion of the lamina retinalis. How-
ever, the development of the macular star is currently understood not as a simple transudation but as a multifactorial process
involving the presence of vascular damage around the optic disk, which is considered one of the most important factors leading
to its occurrence.
Although some studies mention the presence of a macular star in patients with NA-AION, we believe that this phenomenon may
be significantly more common than the current literature suggests.
Keywords: Non-arteritic anterior ischemic optic neuropathy, Lipid deposits, Macular hemistar, Diabetes mellitus, Neuroretinitis,
Macular edema
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One of the risk factors for the development of non-arteritic
anterior ischemic optic neuropathy (NA-AION) is the pres-
ence of diabetes mellitus (DM).1–3
NA-AION does not appear to have a worse prognosis in
diabetic patients compared with non-diabetics in terms of
visual acuity (VA) and visual field impairment at 6 months
after onset.1
However, NA-AION does exhibit some peculiar character-
istics in diabetic patients:
- involvement or recurrence of NA-AION in the contralat-
eral eye is more common in diabetics.1- clinical detection of incipient NA-AION (i.e., in the asymp-
tomatic phase for the patient) is more common in
diabetics.1
- in diabetics, optic disk edema takes longer to resolve than
in non-diabetics.1
- optic disk edema in diabetics with NA-AION is character-
istically associated with the presence of prominent telangi-
ectasias and more abundant retinal hemorrhages
compared with non-diabetics.1
All of these features lead us to the conclusion that NA-
AION is a condition that manifests unique characteristics in
diabetics relative to the rest of the population.e:
al.com
72 A. Galvez-RuizIn some diabetic patients with NA-AION, lipid deposits
can be observed around the macula forming an incomplete
macular star. Usually, these exudates appear when the optic
disk swelling begins to resolve, and they are not typically
present during the period of acute VA loss.4–6 Although some
studies mention the presence of a macular star in patients
with NA-AION, we believe that this phenomenon may be
more common than has been previously reported in the
literature.
We present a series of 12 clinical case studies of patients
with NA-AION in whom the presence of an incomplete mac-
ular star was detected.Clinical case studies
We present 12 patients with NA-AION who developed
lipid deposits around the macula in the form of a macular
hemistar over the course of their illness. Table 1 describes
the following clinical characteristics for all patients: age, gen-
der, the presence of unilateral or bilateral NA-AION, the exis-
tence of vascular risk factors, such as diabetes mellitus or
hypertension, VA in the acute phase and after patient fol-
low-up, color vision, visual field testing results, the onset of
macular star formation, the presence of diabetic retinopathy,
and cranial and orbital MRI findings.
Mean age of patients in our series was 55 years, with an
age range of 43–73 years. 5 patients out of 12 presented with
bilateral NA-NAION, calling attention to the fact that in two
cases the clinical presentation was simultaneous in both eyes.
It was striking to find cases of bilateral NA-AION in which
the macular star was only observed in one eye (patients 2, 11
and 12). If the development of lipid deposits is related to vas-
cular involvement around the optic disk (as will be argued in
the discussion), then it would be assumed a priori that the
microvascular involvement would be symmetrical in both
eyes, with the symmetrical development of macular lipid
deposits.
All of the patients were diabetic, except patient 10, who
was only hypertensive. In all patients, the macular star was
incomplete (hemistar). 6 patients in our study had NPDR
(non-proliferative diabetic retinopathy) and 6 other patients
had no DR (diabetic retinopathy). Regarding the presence
of vascular risk factors, 7 patients out of 12 had hypertension.
The initial mean VA of our patients was 20/300 (consider-
ing only the affected eye). The VA improved significantly in 4
patients after several months of development, remaining
without significant changes in the rest of patients. The aver-
age follow-up time for our series was 7.4 months with a range
of 4–12 months. Regarding the color vision measured with
the Ishihara test, there was a great variability in the eyes with
NA-NAION with a range from 0/15 to 15/15 and an average
of 2/15.
It was also observed a large variability in the visual field
defects in the affected eyes: 2 patients had superior altitudi-
nal defect; 5 patients, inferior altitudinal defect; 2 patients,
central scotoma; 4 patients with inferior-nasal defect and
two patients with residual islet.
The time required for the formation of the macular star in
the series presented varied between 1 week and 8 weeks. In
this regard, one important limitation of our study should be
mentioned: we considered the time of the macular star’s
appearance to be the first visit at which it is detected. How-ever, it is possible that lipid deposits may have already been
present prior to the visit. In fact, there were cases in which
the macular star was already disappearing when it was first
observed (patients 2, 5, 6 and 8).
Fig. 1 shows the fundi in patients 1–12.
Only one patient experienced neurosensory elevation or
ophthalmoscopically observed detachment due to the accu-
mulation of subfoveal fluid (patient 12). These findings were
confirmed by performing optical coherence tomography
(OCT) (Fig. 2).Discussion
In this paper, we presented a clinical series of 12 patients
with NA-AION in whom lipid deposits were detected around
the macula during the clinical course of their disease (usually
coinciding with the resolution of the optic disk edema) form-
ing an incomplete macular star or a hemistar.
To start with this discussion we will comment the fre-
quency of the possible etiologies that may be responsible
for the pattern of optic disk edema with macular star, Chang
et al.7 published a report of a series of 173 eyes presenting
with optic neuropathy of different etiologies. Only 23 had
macular lipid exudates accompanying optic disk edema. Of
these 23 eyes, 15 had neuroretinitis, 6 had NA-AION, and 2
were secondary to papilledema. Particularly for the NA-AION
group, these authors found a clear correlation between mac-
ular star appearance and the age of patients as well as the
existence of diabetes mellitus (DM) and arterial hypertension.
It is also noteworthy that there was no worsening of VA sec-
ondary to the presence of lipid exudation in this study. This
result suggests that decreased VA is due to the presence of
optic nerve involvement but not to lipid exudates.
In our series, it was difficult to establish a relationship
between the macular star and the deteriorating VA, mainly
because VA varies greatly in NA-AION, and in many cases,
VA is not recovered. The most common visual field defect
in patients with NA-AION is an absolute inferonasal defect
followed by a relative inferior altitudinal defect.8 We suggest
that if parafoveal lipid deposits cause visual field changes,
these would have to consist of a central defect. In this regard,
of the cases presented, 9 eyes (patients 1, 2 left eye, 3 right
eye, 4, 5, 7, 8, 11 and 12) had visual field defects typical of
NA-AION, and only 4 eyes (patient 2 right eye, 3 left eye, 6
and 10) had absolute central defects. Thus, we can conclude
that only 4 eyes in our series (30.7%) could hypothetically
have visual field defects attributable to the presence of lipid
deposits.
Between the different etiologies mentioned before, the
association of optic disk edema and lipid deposits in the form
of a macular star occurs mainly in a condition called neuroret-
initis. This condition may be idiopathic or secondary to syphi-
lis, cat-scratch disease (CSD), Lyme disease and toxoplasmosis
(although there is a long list of infectious agents listed as
potential pathogenetic agents in different studies).9–11
In neuroretinitis, the primary process involves optic nerve
inflammation causing a secondary lipid exudate in the macula
(although there are cases of genuine retinitis, especially in
CSD).9,12 Lipid deposits are often not evident initially but
develop approximately 9–12 days after the appearance of
the optic disk edema.9,12
Table 1. This table describes the following clinical characteristics for patients 1–12: age, gender, the presence of unilateral or bilateral NA-AION, the
existence of vascular risk factors, such as diabetes mellitus or hypertension, visual acuity in the acute phase and after patient follow-up, color vision, visual
field testing defects, the onset of macular star formation, the presence of diabetic retinopathy, and cranial and orbital MRI findings.
Age/
gender
NA-AION DM HBP VA/Initial VA/Final Color
vision
VF Onset of
Macular star
formation
(weeks)
Presence of
diabetic
retinopathy
MRI
1 72 years
Male
Bilateral
(sequential)
RE 7/2011
LE 9/2011
+  1/200
1/200
1/200
1/200
Follow-up:
6 months
0/15
0/15
BE: inferior
altitudinal
defect
RE: 8 weeks
LE: not
present
No Signs of
chronic
ischemia
2 73 years
Male
Bilateral
(simultaneous)
+  2/200
20/30
20/25
20/25 Follow-up:
1 year
1/15
15/
15
RE: central
scotoma
LE: superior
altitudinal
central
scotoma
RE: 3 weeks
LE: not
present
Yes (non-
proliferative)
Normal
3 53 years
Male
Bilateral
(sequential)
RE: 3/2011
LE: 3/1012
+ + 20/30
Hand
movements
20/25
Counting fingers
Follow-up:
1 year
1/15
0/15
RE: inferior
nasal defect
LE: residual
temporal
island
RE: ? (previous
NA-AION
episode)
LE: 4 weeks
Yes (non-
proliferative)
Signs of
chronic
ischemia
4 43 years
Male
Unilateral
RE:
Old CRVO LE.
+  20/400
5-6/200
20/400
5-6/200
Follow-up:
6 months
0/15
0/15
RE: relative
superior
altitudinal
defect
LE:
cecocentral
defect
RE: 1 week No Normal
5 60 years
Female
Unilateral
LE
+ - 20/25
CF
20/25
CD
Follow-up:
7 months
13/
15
0/15
RE: normal
LE: superior
altitudinal
defect
LE: 3 weeks Yes (non-
proliferative)
–
6 56 years
Male
Unilateral
LE
+ + 20/20
20/200
20/20
20/25
Follow-up:
1 year
15/
15
0/15
RE: normal
LE:
cecocentral
scotoma
LE: 4 weeks No Normal
7 52 years
Female
Unilateral
RE
+ + 20/300
20/60
20/100
20/25
Follow-up:
4 months
1/15
15/
15
RE: normal
LE:
nasal and
superior nasal
scotoma
RE: 4–5 weeks Yes (non-
proliferative)
–
8 55 years
Male
Unilateral
RE
+ + 20/50
20/40
20/40
20/40
5 months
8/15
15/
15
RE: inferior
nasal absolute
scotoma
LE: normal
RE: 3 weeks Yes (non-
proliferative)
Ischemic
lesions
9 54 years
Male
Unilateral
RE
+ + 20/200
20/20
20/80
20/20
Follow-up:
5 months
0/15
15/
15
RE: central
residual island
(reliable?)
LE: normal
RE: 4 weeks No –
10 52 years
Male
Unilateral
RE
 + 2/200
20/20
2/200
20/20
Follow-up:
6 weeks
0/15
15/
15
RE: central
and superior
altitudinal
scotoma
LE: normal
RE: 4 weeks No Ischemic
brain changes
11 46 years
Male
Bilateral
RE 4/2011
LE 1/2013
+ + 1/200
20/20
20/400
1/200
Follow-up:
8 months
0/15
0/15
RE: inferior
nasal defect
LE: superior
altitudinal
defect.
Concentric
reduction
RE: 4 weeks
LE: no
development
Yes (non-
proliferative)
–
12 44 years
Male
Simultaneous
bilateral
RE/LE
(RE probable
diabetic
papillopathy)
+  20/20
20/300
20/20
20/40
4-6 weeks
15/
15
6/15
RE: normal
LE: inferior
altitudinal
defect
RE: no
development
LE: 1 week
No MRI: Normal
OCT:
neurosensory
elevation LE
Abbreviations: NA-AION: non-arteritic anterior ischemic optic neuropathy; DM: Diabetes Mellitus; HBP: High blood pressure; VA: visual acuity; VF: visual field; MRI: Magnetic
resonance imaging; RE: right eye; LE: left eye; BE: both eyes; CRVO: Central retinal artery occlusion; OCT: optical coherence tomography.
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Figure 1. Fundus appearance in patients 1–12.
Figure 2. Optical coherence tomography (OCT) showing neurosensory detachment due to subfoveal fluid accumulation in patient 12.
74 A. Galvez-RuizAs mentioned in the results, in our study, the time to the
formation of the macular star in the series presented varied
between 1 week and 8 weeks. In this regard, one important
limitation of our study should be mentioned: the time of
onset of the macular star was considered to be the first visit
at which it was detected. Therefore, it is possible that lipid
deposits were present prior to the visit. In fact, there were
cases in which the macular star was already disappearing
when it is first observed (patients 2, 5, 6 and 8). In such cases,
it was obvious that the onset occurred prior to the visit.
Therefore, although our results appear to suggest that the
macular hemistars in our series appeared later compared
with the findings of Brazis et al. and Purvin et al. for patients
with neuroretinitis 9,12, these results must be interpreted with
caution.Regardless of the exact timing of the macular hemistar for-
mation, it is clear that its formation occurs only after the
onset of optic disk edema. Therefore, its presence can be
easily overlooked if a second fundus examination is not per-
formed after the acute phase of NA-AION. The low fre-
quency at which cases involving the formation of a macular
star are reported in the scientific literature may be due not
only to the fact that this condition is most likely not very com-
mon but also that it can be overlooked if a second fundus
examination is not performed within the first weeks of its
development.
In some patients, it is necessary to make a differential
diagnosis between a macular star secondary to neuroretinitis
(NR) and to NA-AION. This differential diagnosis is based
mainly on the age of onset (younger patients in cases of
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occurrence of macular stars secondary to NA-AION is charac-
terized by permanent visual field defects and a lack of VA
recovery; these outcomes are in contrast to neuroretinitis,
after which most patients have an excellent recovery. It is also
worth mentioning that the macular star is not usually com-
plete in patients with NA-AION, unlike in the cases of
neuroretinitis.12
Perhaps this clinical series shows that if a diabetic patient
presents with sudden VA loss, optic disk edema and incom-
plete macular star formation, it is most likely a case of NA-
AION. In these cases, it would most likely be unnecessary
to request laboratory tests to rule out infectious agents asso-
ciated with neuroretinitis.
With regard to the etiopathogenesis it is hypothesized
that macular stars form from the transudation of deep capil-
laries in the optic disk.7,8 Such transudation occurs through
the intermediary tissue of Kuhnt, located between the retina
and the anterior portion of the lamina retinalis. Some authors
have reported that this tissue functions as a blood-optic
nerve barrier.7,13,14 With the breakdown of this barrier, fluid
transudation from the optic nerve would reach the macula,
specifically the outer plexiform layer. As a result of the radial
configuration of this layer, the star pattern12 tends to occur.
In some cases, fluid transudation can cause neurosensory
detachment.12 However, other factors have also been pro-
posed that could favor macular star formation, including
altering the barrier function of the border tissue of Elschnig,
a lack of self-regulation of the short ciliary arteries, a high
level of serum cholesterol, and the presence of retinal
microangiopathy.7,13
Thus, although the development of a macular star can be
understood not as simple transudation but rather as a multi-
factorial process, there is a consensus that one of the most
important factors leading to its occurrence is the presence
of vascular compromise around the optic disk. This process
would partially explain why macular star occurs more fre-
quently in diabetic patients with NA-AION.7
Regarding the limitations of this study, as we said before,
it should be mentioned: the time of onset of the macular star
was considered to be the first visit at which it was detected.
Therefore, it is possible that lipid deposits were present prior
to the visit.
Also, in only one of our patients was neurosensory eleva-
tion or detachment due to subfoveal fluid accumulation
observed on OCT (patient 12). We recognize that OCT was
not performed systematically on the remaining patients,
and this was another limitation of the present study. How-
ever, no signs of subfoveal neurosensory detachment were
observed ophthalmoscopically in the other patients.
In conclusion, in this study, we presented 12 patients with
NA-AION (11 of whom were diabetic) in whom lipid depositsaccumulated around the macula during the course of their
disease, forming a macular hemistar. These findings reinforce
the idea that NA-AION exhibits a number of unique charac-
teristics in diabetics compared with the rest of the popula-
tion. Moreover, although studies that mention the presence
of a macular star in NA-AION have been published, we
believe that this phenomenon may be more common than
the current literature suggests.Conflict of interest
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